Daliom Biopharmaceuticals is a Swiss-based holding company devoted to the development of biopharmaceutical technology, therapeutics and products
About Us
As a holding company we are committed to investing our assets in improving patient outcomes and quality of life through the development of innovative biopharmaceutical products.
As such, Daliom Biopharmaceuticals is working with highly skilled scientists and researchers with expertise in areas such as immunology, oncology, and neurology. We have close ties to India for research, development & production of biopharmaceutical products.
Overall, Daliom Biopharmaceuticals vision is to grow into a dynamic and innovative biopharmaceutical company that is dedicated to improving patient outcomes through the development of novel therapies.
